Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2002 Nov 9;325(7372):1073-5.
doi: 10.1136/bmj.325.7372.1073.

Oral anticoagulation and risk of death: a medical record linkage study

Anders Odén  1 , Martin Fahlén
Affiliations
Multicenter Study

Oral anticoagulation and risk of death: a medical record linkage study

Anders Odén et al. BMJ. .

Abstract

Objective: To study how mortality varies with different degrees of anticoagulation reflected by the international normalised ratio (INR).

Design: Record linkage analysis with death hazard estimated as a continuous function of INR.

Data sources: 46 anticoagulation clinics in Sweden with computerised medical records.

Subjects: Records for 42 451 patients, 3533 deaths, and 1.25 million INR measurements.

Main outcome measures: Mortality from all causes and from intracranial haemorrhage.

Results: Mortality from all causes of death was strongly related to level of INR. Minimum risk of death was attained at 2.2 INR for all patients and 2.3 INR for patients with mechanical heart valve prostheses. A high INR was associated with an excess mortality: with an increase of 1 unit of INR above 2.5, the risks of death from cerebral bleeding (149 deaths) and from any cause were about doubled. Among patients with an INR of > or =3.0, 1069 deaths occurred within 7 weeks; if the risk coincided with that with an INR of 2.9, the expected number of deaths would have been 569. Thus at least 500 deaths were associated with a high INR value, but not necessarily caused by the treatment.

Conclusions: The excess mortality associated with high INR values supports the use of less intensive treatment and a small therapeutic window, with INR close to 2.2-2.3 irrespective of the indication for anticoagulant treatment. More preventive actions should be taken to avoid episodes of high INR.

PubMed Disclaimer

Figures

Figure
Figure
Risk of death associated with different levels of anticoagulation. The curve was calculated from the results of the Poisson model and shows, as an example, the risk for women aged 72: mean risk was 47.6 per 1000 patient years, attained roughly at INR values of 1.6 or 2.9
See this image and copyright information in PMC

References

    1. Turpie AG. Safer anticoagulant therapy after heart valve replacement. Recommendations for less intense regimens. Postgrad Med. 1997;101:85–86. , 89-90, 93-4. - PubMed
    1. Hirsh J. Optimal intensity and monitoring warfarin. Am J Cardiol. 1995;75:39–42. B. - PubMed
    1. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest. 2001;119:220–27S. - PubMed
    1. Katircioglu SF, Yamak B, Ulus AT, Iscan HZ, Mavitas B, Tasdemir O. Aortic valve replacement with the St. Jude Medical prosthesis and fixed dose anticoagulation. J Card Surg. 1997;12:363–370. - PubMed
    1. Katircioglu SF, Yamak B, Ulus AT, Tasdemir O, Bayazit K. Mitral valve replacement with St. Jude Medical prosthesis and low-dose anticoagulation in patients aged over 50 years [see comments] J Heart Valve Dis. 1998;7:455–459. - PubMed

Publication types